Estonia - Estonian - Ravimiamet

ideal trade links uab - deksametasoon - tablett - 20mg 10tk; 20mg 50tk; 20mg 30tk; 20mg 20tk

European Union - Estonian - EMA (European Medicines Agency)

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastilised ained - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

Estonia - Estonian - Ravimiamet

teva b.v. - kolekaltsiferool - pehmekapsel - 20000rÜ 50tk; 20000rÜ 30tk; 20000rÜ 4tk; 20000rÜ 10tk

Estonia - Estonian - Ravimiamet

teva b.v. - kolekaltsiferool - pehmekapsel - 50000rÜ 1tk; 50000rÜ 4tk; 50000rÜ 2tk

Estonia - Estonian - Ravimiamet

patent pharma kft. - kolekaltsiferool - õhukese polümeerikattega tablett - 30000rÜ 2tk; 30000rÜ 4tk; 30000rÜ 3tk